There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. After-hours trades for Novo Nordisk ADR (NVO) shows that investor sentiment remained intact, with the stock’s consolidated last price rising by $0.10, or 0.10%, to $101.79. The Novo Nordisk ADR has recorded 10,797 volume in the after hours trading session. Yahoo Finance discussed the stock recently as it posted Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons.
This NYSE-listed company operates within the Biotechnology industry segment, falling under the Healthcare sector. At the end of the last regular session, the stock closed at $101.69 and fluctuated between $102.00 as its day high and $100.56 as its day low. The current market capitalization of Novo Nordisk ADR is $343.20B. A total of 4.36 million shares were traded on the day, compared to an average of 4.65M shares.
The income generated by dividends is an indication that a company is improving its financial position, which is why investors prefer companies paying dividends. Novo Nordisk ADR pays an annual dividend of $1.27, resulting in a dividend yield of 1.25%, and it has a price to earnings (P/E) ratio of 42.26. NVO’s most recent ex-dividend date was 8/18/2023 when it declared a $0.2209 quarterly dividend that was paid in cash on 8/29/2023. Previously, the company paid the dividend on 4/4/2023 with an ex-dividend date of 3/24/2023. The NVO stock dividend was $0.2972 per share in cash.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. According to analysts who have offered 12-month price targets for NVO in the last 3 months, the mean price target is $102.89 with high estimates of $126.05 and low estimates of $50.84. In terms of 52-week highs and lows, NVO has a high of $104.00 and a low of $54.85.
As of this writing, NVO has an earnings estimate of $GraniteShares 1.5x Short NVDA D per share for the current quarter. EPS was calculated based on a consensus of NIO Inc. estimates, with a high estimate of $Novo Integrated Sciences, Inc. per share and a lower estimate of $Novo Nordisk A/S.
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. NVO’s latest balance sheet shows that the firm has $17.48B in Cash & Short Term Investments as of fiscal 2021. There were $26.64B in debt and $99.52B in liabilities at the time. Its Book Value Per Share was $3.37, while its Total Shareholder’s Equity was $70.75B.
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for NVO is Buy with a score of 4.63.